Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
4.15%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 3.2Close
$ 0.43 - $ 3.45 52-Week Range
Ticker Information
Ticker
CTMXCompany Name
CYTOMX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCYTOMX THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CTMX - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 5.85M | 4.15% | $ 141.1M |
| 3/31/2025 | $ 5.87M | 3.97% | $ 147.56M |
| 12/31/2024 | $ 5.85M | 4.24% | $ 138.1M |
| 9/30/2024 | $ 5.83M | 4.61% | $ 126.62M |
| 6/30/2024 | $ 5.8M | 4.85% | $ 119.57M |
| 3/31/2024 | $ 5.86M | 4.92% | $ 119.18M |
| 12/31/2023 | $ 5.9M | 5.83% | $ 101.21M |
| 9/30/2023 | $ 5.94M | 7.87% | $ 75.55M |
| 6/30/2023 | $ 6M | 9.08% | $ 66.08M |
| 3/31/2023 | $ 5.92M | 9.95% | $ 59.52M |
Key Performance Insights, Last 5 Years
- CYTOMX THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 2.73%.
- Over the past 5 years, CYTOMX THERAPEUTICS INC's average DepAmor % has been 7.17%.
- The median DepAmor % for CYTOMX THERAPEUTICS INC during this period was 7.95%
- CYTOMX THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 11.94%.
- The lowest DepAmor % recorded by CYTOMX THERAPEUTICS INC in the same timeframe 2.73%
CYTOMX THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for CYTOMX THERAPEUTICS INC is calculated as follows: DepAmor [ $ 2.52M ] / Revenues [ $ 92.27M ]
(=) DepAmor % [ 2.73% ] CTMX - Depreciation and Amortization Margin, Last 5 years
2.73%
Minimum
Sep 30, 2020
11.94%
Maximum
Sep 30, 2021
7.17%
Average
7.95%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |